P-014 Efficacy and Safety of ABBV-383, a BCMA Bispecific Antibody, in Black Patients with Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of a Phase 1 Trial
Clinical Lymphoma Myeloma and Leukemia(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要